Wednesday
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY: DEB AND DES ALTERNATIVES TO PACLITAXEL AND RELATED ISSUES
Location: Grand Ballroom East, 3rd Floor
Moderators:Kenneth Ouriel, MD, MBA / Sahil A. Parikh, MD  
SESSION 25 SCHEDULE
9:00 AM - 9:05 AM Older And More Recent Meta-Analyses Still Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: The More Recent Study Of DCBs In BTK Arteries Showed Increased Mortality And Amputation Rates After Only 1 Year
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:06 AM - 9:11 AM An Update Of The Real-World Evidence Evaluating Paclitaxel Coated Device Safety In Treating Fempop And Crural Artery Lesions: The SAFE-PAD Study
  Presenter(s):Eric A. Secemsky, MD, MSc  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:12 AM - 9:17 AM The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data: Letís Put 4 Years Of Frenetic Activity Into Perspective
  Presenter(s):Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:18 AM - 9:23 AM

Power Point Presentation with Synched Audio
Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices
  Presenter(s):Christian A. Behrendt, MD  
Location: Grand Ballroom East, 3rd Floor
9:24 AM - 9:29 AM The SWING Study: First In Human Use Of A Sirolimus DCB In Arteries Below-The-Knee
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Andrew Holden, MBChB / Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:30 AM - 9:35 AM Alternatives To Paclitaxel Coated Devices For Limiting Intimal Hyperplasia After Treatment: Sirolimus Coating, Bioresorbables And Adventitial Drug Delivery With The Bullfrog Device: How Do Paclitaxel And Limus Drugs Work And How Do They Differ
  Presenter(s):William A. Gray, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:36 AM - 9:41 AM Progress And Problems With A Sustained Release Limus DCB: 3-Year Results With The Magic Touch DCB: From The SIRONA Study
  Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:42 AM - 9:47 AM

Power Point Presentation with Synched Audio
The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions
  Presenter(s):Marianne Brodmann, MD  
Location: Grand Ballroom East, 3rd Floor
9:48 AM - 9:53 AM Key New Developments In Endovascular Treatments For CLTI
  Presenter(s):Sahil A. Parikh, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:54 AM - 9:59 AM Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached)
  Presenter(s):Theodosios Bisdas, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:00 AM - 10:08 AM Panel Discussion
10:08 AM - 10:18 AM Lunch Break Ė Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25
previous next